Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial.
Clinical trial NCT07593482 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07593482
- Sponsor
- Swiss Cancer Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2029-03-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.